The FDA has taken another step towards realizing their vision for encouraging pharmaceutical quality management practices. FDA’s Center for Drug Evaluation and Research (CDER) has developed …
FDA Encourages Industry to Achieve Quality Management Maturity (QMM) Read More »
FDA’s Center for Drug Evaluation and Research (CDER) recently released its fifth annual report on the State of Pharmaceutical Quality. It reviews the state of …
FDA Reports on the State of Pharmaceutical Quality Read More »
The Inflation Reduction Act (IRA) will drive a significant change in the pharmaceutical industry, empowering Medicare to negotiate the prices of high-cost single-source brand-name drugs …
Price Controls: 10 Initiatives Pharma Must Consider To Mitigate Impacts Read More »
An Axendia “Straight from the Source” Event Axendia revealed its 2023 Life Sciences Radar on February 2, 2023, during a live event. Members of our …
Life Science Industry Predictions for 2023 and Beyond! Read More »
